Cargando…
In vitro immuno-nanotoxicological methods that take pre-existing conditions into account
Autores principales: | Himly, M., Johnson, L., Mills-Goodlet, R., Hasenkopf, I., Hofer, S., Hofstaetter, N., Geppert, M., Duschl, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461782/ http://dx.doi.org/10.1016/S0378-4274(21)00282-4 |
Ejemplares similares
-
Nanomaterials in the Context of Type 2 Immune Responses—Fears and Potentials
por: Himly, Martin, et al.
Publicado: (2017) -
Mechanisms of Particles in Sensitization, Effector Function and Therapy of Allergic Disease
por: Joubert, Isabella Anna, et al.
Publicado: (2020) -
Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations
por: Hofer, Sabine, et al.
Publicado: (2022) -
Nanotoxicology
por: Kalantari, Heibatullah
Publicado: (2013) -
Nanotoxicology: in Vitro–in Vivo Dosimetry
por: Oberdörster, Günter
Publicado: (2012)